DekaBank Deutsche Girozentrale
CBIO

DekaBank Deutsche Girozentrale’s Crescent Biopharma CBIO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-218
Closed -$251K – 1044
2019
Q2 		$251K Buy
218
+84
+63% +$100K ﹤0.01% 994
2019
Q1 		$200K Buy
134
+25
+23% +$28.6K ﹤0.01% 1042
2018
Q4 		$95K Sell
109
-25
-19% -$30.1K ﹤0.01% 1065
2018
Q3 		$200K Sell
134
-3
-2% -$4.54K ﹤0.01% 1063
2018
Q2 		$216K Hold
137
– – ﹤0.01% 1035
2018
Q1 		$220K Buy
+137
New +$285K ﹤0.01% 982

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return

DekaBank Deutsche Girozentrale's CBIO Position: Q3 2019 in Review

DekaBank Deutsche Girozentrale sold out of Crescent Biopharma (CBIO) in Q3 2019, closing a stake of 218 shares — an estimated $251K sold.

DekaBank Deutsche Girozentrale first reported a position in CBIO in Q1 2018 and held it in 6 quarters. The position peaked at $251K in Q2 2019. 75 funds tracked by Wall St. Rank hold CBIO as of Q3 2019.

  • DekaBank Deutsche Girozentrale reported no remaining Crescent Biopharma position as of Q3 2019 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 218 Crescent Biopharma shares in Q3 2019, an estimated $251K.
  • DekaBank Deutsche Girozentrale first reported a position in Crescent Biopharma in Q1 2018 and held it in 6 quarters.
  • DekaBank Deutsche Girozentrale's Crescent Biopharma position peaked at $251K in Q2 2019.
  • 75 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2019.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2019, filed 14 Nov 2019.